Diagnoses for overactive bladder more than tripled between 2013 and 2017, after the American Urological Association (AUA) released guidelines for the condition in 2012, researchers found. However, ...

AUA 2023: Phase 3 Randomized Study of Enzalutamide or Placebo Plus Leuprolide Acetate and Enzalutamide Monotherapy in High-Risk Biochemically Recurrent Prostate Cancer: EMBARK AUA 2023: Role and ...

AUA 2023: Machine Learning Prediction of Symptomatic Kidney Stone Recurrence Using 24-Hour Urine Data and Electronic Health Record Derived Features AUA 2023: A Novel Machine-Learning Algorithm to ...

Benefits from drugs are small." In partnership with the Society of Urodynamics and Female Urology, the AUA published. Diagnosis and Treatment of Overactive Bladder (non-Neurogenic) in Adults ...

The Program Committee of the AUA has accepted the Theralase®'s abstract ... Clinical Study of BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In-Situ" for presentation in a Podium ...

Diagnoses for overactive bladder more than tripled between 2013 and 2017, after the American Urological Association (AUA) released guidelines for the condition in 2012, researchers found.

The Program Committee of the AUA has accepted the Theralase®'s abstract titled: "Interim Analysis of Light-Activated TLD-1433 in a Phase II Clinical Study of BCG-Unresponsive Non-Muscle Invasive ...

The Program Committee of the AUA has accepted the Theralase®'s abstract titled: 'Interim Analysis of Light-Activated TLD-1433 in a Phase II Clinical Study of BCG-Unresponsive Non-Muscle Invasive ...